A UK based cost-utility analysis of indacaterol, a once-daily maintenance bronchodilator for patients with COPD, using real world evidence on resource use

Price, D; Asukai, Y; Ananthapavan, Jaithri; Malcolm, B; Radwan, A; Keyzor, I

A UK based cost-utility analysis of indacaterol, a once-daily maintenance bronchodilator for patients with COPD, using real world evidence on resource use

https://hdl.handle.net/10536/DRO/DU:30062770
Open external identifier URL

journal contribution

posted on 2013-06-01, 00:00 authored by D Price, Y Asukai, Jaithri AnanthapavanJaithri Ananthapavan, B Malcolm, A Radwan, I Keyzor

A UK based cost-utility analysis of indacaterol, a once-daily maintenance bronchodilator for patients with COPD, using real world evidence on resource use

History

Related Materials

1.
DOI - Is version of https://doi.org/10.1007/s40258-013-0021-5

Location

Berlin, Germany

Open access

Yes

Link to full text

https://link.springer.com/content/pdf/10.1007/s40258-013-0021-5.pdf

Language

eng

Publication classification

C1.1 Refereed article in a scholarly journal

Copyright notice

2013, Springer

Journal

Applied health economics and health policy

Volume

11

Pagination

259 - 274

ISSN

1175-5652

eISSN

1179-1896

Usage metrics

Keywords

chronic obstructive pulmonary disease (COPD)bronchodilators UK National Health Service (NHS) perspective cost effectiveness indacaterol long-acting beta2-agonist (LABA)tiotropium salmeterol Social Sciences Science & Technology Life Sciences & Biomedicine Economics Health Care Sciences & Services Health Policy & Services Business & Economics

A UK based cost-utility analysis of indacaterol, a once-daily maintenance bronchodilator for patients with COPD, using real world evidence on resource use

History

Related Materials

Location

Open access

Link to full text

Language

Publication classification

Copyright notice

Journal

Volume

Pagination

ISSN

eISSN

Usage metrics

Categories

Keywords

Licence

Exports